Home / Inspections / 1266335

FDA Inspection 1266335 — Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. — FEI 3004664441

The FDA completed an inspection of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. on March 14, 2025 in Nanjing. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 14, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Nanjing (China)

Facility

Other inspections at this facility

  • 1050487 (NAI Fri Mar 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 934692 (VAI Fri May 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 812363 (VAI Fri Dec 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 709563 (NAI Thu Oct 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 614662 (NAI Fri Sep 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources